LOGSX vs. JNGLX

Last updated Aug 1, 2026

LOGSX (Live Oak Health Sciences Fund) and JNGLX (Janus Henderson Global Life Sciences Fund) are both Health & Biotech Equities funds. Over the past 10 years, LOGSX returned 7.52%/yr vs 11.16%/yr for JNGLX. Their correlation of 0.84 means they have usually moved in the same direction. LOGSX charges 1.02%/yr vs 0.80%/yr for JNGLX.

Performance

LOGSX vs. JNGLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Live Oak Health Sciences Fund (LOGSX) and Janus Henderson Global Life Sciences Fund (JNGLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with LOGSX having a 9.56% return and JNGLX slightly lower at 9.53%. Over the past 10 years, LOGSX has underperformed JNGLX with an annualized return of 7.52%, while JNGLX has yielded a comparatively higher 11.16% annualized return.

LOGSX

• 1D: -0.31%
• 1M: 0.66%
• 6M: 7.55%
• YTD: 9.56%
• 1Y: 30.03%
• 3Y*: 11.24%
• 5Y*: 7.16%
• 10Y*: 7.52%
• ALL TIME*: 7.86%

JNGLX

• 1D: -0.67%
• 1M: -1.71%
• 6M: 8.69%
• YTD: 9.53%
• 1Y: 41.17%
• 3Y*: 13.42%
• 5Y*: 8.67%
• 10Y*: 11.16%
• ALL TIME*: 11.53%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
JNGLX Janus Henderson Global Life Sciences Fund	$0.00	$0.00	$0.00
LOGSX Live Oak Health Sciences Fund	$0.00	$0.00	$0.00

LOGSX vs. JNGLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LOGSX Live Oak Health Sciences Fund	9.56%	19.63%	0.16%	1.21%	3.71%	17.59%	6.01%	18.98%	-3.84%	13.42%
JNGLX Janus Henderson Global Life Sciences Fund	9.53%	24.84%	3.60%	7.51%	-2.69%	6.78%	25.66%	29.20%	4.17%	22.13%

Correlation

The correlation between LOGSX and JNGLX is 0.82, meaning they have usually moved in the same direction, including during past declines.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.82
Correlation (3Y) Balances recent behavior with more history.	0.78
Correlation (5Y) Shows whether the relationship held over a longer period.	0.83
Correlation (10Y) Provides a long-term view across more market conditions.	0.82
Correlation (All Time) Calculated using the full available price history since Jun 29, 2001	0.84

The correlation between LOGSX and JNGLX has been stable across timeframes, ranging from 0.78 to 0.84 - a consistent structural relationship.

Return for Risk

LOGSX vs. JNGLX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LOGSX

LOGSX Risk / Return Rank: 78
LOGSX Sharpe Ratio Rank: 79
LOGSX Sortino Ratio Rank: 78
LOGSX Omega Ratio Rank: 73
LOGSX Calmar Ratio Rank: 90
LOGSX Martin Ratio Rank: 70

JNGLX

JNGLX Risk / Return Rank: 92
JNGLX Sharpe Ratio Rank: 95
JNGLX Sortino Ratio Rank: 92
JNGLX Omega Ratio Rank: 86
JNGLX Calmar Ratio Rank: 95
JNGLX Martin Ratio Rank: 91

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LOGSX vs. JNGLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Live Oak Health Sciences Fund (LOGSX) and Janus Henderson Global Life Sciences Fund (JNGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LOGSX	JNGLX	Difference
Sharpe ratio: Return per unit of total volatility	1.87	2.52	-0.66
Sortino ratio: Return per unit of downside risk	2.72	3.63	-0.91
Omega ratio: Gain probability vs. loss probability	1.32	1.43	-0.11
Calmar ratio: Return relative to maximum drawdown	3.41	4.11	-0.70
Martin ratio: Return relative to average drawdown	8.71	12.85	-4.14

LOGSX vs. JNGLX - Sharpe Ratio Comparison

The current LOGSX Sharpe Ratio is 1.87, which is comparable to the JNGLX Sharpe Ratio of 2.52. The chart below compares the historical Sharpe Ratios of LOGSX and JNGLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LOGSX vs. JNGLX - Drawdown Comparison

The maximum LOGSX drawdown since its inception was -45.85%, smaller than the maximum JNGLX drawdown of -59.00%. Use the drawdown chart below to compare losses from any high point for LOGSX and JNGLX.

Drawdown Indicators

	LOGSX	JNGLX	Difference
Max Drawdown Largest peak-to-trough decline	-45.85%	-59.00%	+13.15%
Max Drawdown (1Y) Largest decline over 1 year	-8.13%	-9.68%	+1.55%
Max Drawdown (3Y) Largest decline over 3 years	-14.33%	-21.17%	+6.84%
Max Drawdown (5Y) Largest decline over 5 years	-15.03%	-22.21%	+7.18%
Max Drawdown (10Y) Largest decline over 10 years	-27.28%	-27.37%	+0.09%
Current Drawdown Current decline from peak	-1.07%	-2.51%	+1.44%
Average Drawdown Average peak-to-trough decline	-7.58%	-17.56%	+9.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.19%	3.09%	+0.10%

Volatility

LOGSX vs. JNGLX - Volatility Comparison

Live Oak Health Sciences Fund (LOGSX) and Janus Henderson Global Life Sciences Fund (JNGLX) have volatilities of 5.35% and 5.23%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LOGSX	JNGLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.35%	5.23%	+0.12%
Volatility (6M) Calculated over the trailing 6-month period	11.21%	12.28%	-1.07%
Volatility (1Y) Calculated over the trailing 1-year period	14.83%	15.75%	-0.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.44%	16.11%	-1.67%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.19%	17.38%	-1.19%

LOGSX vs. JNGLX - Expense Ratio Comparison

LOGSX has a 1.02% expense ratio, which is higher than JNGLX's 0.80% expense ratio.

Dividends

LOGSX vs. JNGLX - Dividend Comparison

LOGSX's dividend yield for the trailing twelve months is around 1.89%, less than JNGLX's 4.17% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JNGLX Janus Henderson Global Life Sciences Fund	4.17%	4.56%	5.84%	4.26%	0.25%	9.85%	7.80%	6.23%	13.32%	0.89%	0.30%	8.81%
LOGSX Live Oak Health Sciences Fund	1.89%	2.07%	2.64%	6.28%	0.55%	7.02%	7.04%	0.85%	15.20%	6.45%	2.10%	15.52%

Frequently Asked Questions

Can I hold both LOGSX and JNGLX in my portfolio?

LOGSX and JNGLX have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LOGSX or JNGLX?

LOGSX has higher volatility (5.35%) compared to JNGLX (5.23%). In terms of maximum drawdown, LOGSX dropped -45.85% vs JNGLX's -59.00%.

Which has better risk-adjusted returns?

JNGLX currently has the higher Sharpe Ratio (2.52 vs 1.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.